Cancer Management and Research
Volume 15, 2023 - Issue
Open access
284
Views
1
CrossRef citations to date
0
Altmetric
REVIEW
Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date
Pedro Luiz Serrano Uson Junior1 Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ, USA;2 HCOR, Hospital do Coração, Sao Paulo, Brazil;3 Center for Personalized Medicine, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
& Mitesh J Borad1 Mayo Clinic Cancer Center, Mayo Clinic, Phoenix, AZ, USACorrespondence[email protected]
Pages 1025-1031
|
Received 27 Apr 2023, Accepted 31 Aug 2023, Published online: 18 Sep 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.